AN1 0.00% 0.8¢ anagenics limited

Clinical Study: Midkine In Multi-Biomarker Prognosis of ACS, page-3

  1. 1,297 Posts.
    lightbulb Created with Sketch. 127
    I like it when these reports mention Cellmid as being one of the top players.
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.